Genprex, Inc.

For the period ended Dec 31, 2025. Filed Mar 30, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 30, 2026

GNPX$2.06-0.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this annual report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized**.**

	GENPREX, INC.
Date: March 30, 2026	By:	/s/ Ryan M. Confer
		Ryan M. Confer
		President, Chief Executive Officer and Chief Financial Officer
		(Principal Executive Officer and Principal Financial and Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Brent M. Longnecker
Signature	Title	Date
/s/ Ryan M. Confer	President, Chief Executive Officer and Chief Financial Officer and Member of the Board of Directors	March 30, 2026
Ryan M. Confer	(Principal Executive Officer and Principal Financial and Accounting Officer)
/s/ Brent M. Longnecker	Member of the Board of Directors	March 30, 2026
/s/ Jose Antonio Moreno Toscano	Chairman of the Board of Directors	March 30, 2026
Jose Antonio Moreno Toscano
/s/ Will R. Wilson, Jr.	Member of the Board of Directors	March 30, 2026
Will R. Wilson, Jr.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.